Navigation Links
California State PTA Issues Statement Regarding President's Veto of SCHIP Legislation
Date:10/3/2007

SACRAMENTO, Calif., Oct. 3 /PRNewswire-USNewswire/ -- Pam Brady, President of the California State PTA, issued the following statement regarding this morning's veto of federal legislation to expand the State Children's Health Insurance Plans (SCHIP) program:

"The President's veto this morning of legislation to expand the SCHIP program is a historic setback for millions of children and families, including approximately 800,000 in California, who need medical insurance. It is unfortunate for these children that the President doesn't share the Congress' bold bipartisan commitment to ensure that as many children as possible have access to quality medical care. The public, as well as the Congress, overwhelmingly supported this legislation. By vetoing the increased funding for SCHIP, the President's action especially damages California's ability to address the critical health care crisis for families. We know without question that healthy children are much more likely to succeed in school, and to be strong contributors to our democratic society and economy -- our leaders must do whatever it takes to give all children the best chance to succeed."

For more information, please contact Carol Kocivar, Vice-President for Education, California State PTA, at (415) 577-1125.

The mission of the California State PTA is to positively impact the lives of all children and families by representing its members and empowering and supporting them with skills in advocacy, leadership, and communications.


'/>"/>
SOURCE California State PTA
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Passive smoking declared as Toxic in California
2. California Employers may need to Fork out more on Health Benefits
3. An urgent need for prison reforms: California!
4. Death by Smog in California
5. PE Minimums Violations:California Schools Blamed
6. California: Go Ahead For Drug Discount Initiative
7. Students Fail In Fitness Test In California
8. Southern California Wildfires Pose Health Risks to Children
9. About One Third of Children Overweight in California
10. Californian Baby Creates History - Born from a Frozen Egg and Sperm
11. Hunt for Sea Delicacy Taking a Toll in California

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., SHENZHEN, China, Nov. 9 /PRNewswire-Asia-Fi...(NYSE: MR ), a leading developer, manufacturer an... today its selected unaudited,financial results fo...r 30,2009. , , Highlights for Operations as o... revenues were $151.1 million, an increase of, ...
(Date:11/9/2009)..., WASHINGTON, Nov. 9 The Church... its Award For Leadership to J.W. "Bill" Marriott ... through progressive free market practices and fos...ture. Mr. Marriott will receive his award at a cer...shington D.C. Four Seasons Hotel. ,, "This is ...
(Date:11/9/2009)...ult may be left atrial enlargement, study finds ,...sity is a major risk factor for left atrial enlarg...tion, stroke and death, a new study shows. , At...thmia (an irregular heart rhythm or heartbeat). ,...en, aged 25 to 74, in Germany who were followed fo...
(Date:11/9/2009)...k likely due to fact that both eye conditions are ... Nov. 9 (HealthDay News) -- Cataract surgery doesn...macular degeneration (AMD), according to a new stu...use of vision loss worsens the other. , "Becaus...ndividuals with cataract also have AMD," wrote Li ...
(Date:11/9/2009)...lity of care increases with longer doctor visits, ...thDay News) -- Family doctors are now taking more ...ore often and improving the quality of visits, a n...with their primary care physicians during office v...r, and overall they seemed to receive better care,...
Breaking Medicine News(10 mins):Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Doctors Spending More Time Now With Patients 2Health News:Doctors Spending More Time Now With Patients 3
...is growing day by day, the New South Wales (NSW) G...uce the queue//. It has decided to allocate to...This step is thought to help cut elective surgery ...go about the attending patients in a smoother mann...
...pted that periodontal disease is not a desirable c...babies, but for the first time researchers from Ca...edicine and the Department of Obstetrics and Gynec...ted Bergeyella Strain from the Oral Cavity to the ...
...ss of the Perinatal Society of Australia & New Zea...babies born prematurely at 23 weeks should be allo... or later must be committed to intensive care.// ...ts that developed the recommendations, said that t...
...rnia finds that vitamin D can have a hand in cance... lots of vitamin D are 50 per cent less likely to ... field read between the lines and hope it could al...akes the vitamin from sunlight, but experts sugges...
...entists of Kaiser Permanente, overweight or obesit...eloping Alzheimer’s disease// later in life. '...y of Neurology’s 58th Annual Meeting in San Diego.... The study participants were evaluated for ov...
... Engineering plans to unveil a reactor with a capa...y that would help// to meet India’s growing demand...of the bio-diesel research department in the colle...partment of mechanical engineering, said his 10-me...
Other Medicine News:Health News:Fuel demand to be met by Bio-diesel 2
(Date:11/9/2009)...wire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Na... the third quarter ended September 30, 2009. ,,...on stockholders in the third quarter of 2009 of $3... loss allocable to common stockholders in the thir...hare, and a net loss allocable to common stockhold...
(Date:11/9/2009)...re/ -- Groundbreaking articles in current issues o...time explore, in depth, the emergence of cannabino...ers and its potential benefits for patients. ,,...gton authors, Sunil Aggarwal, PhD who is a member ...ram and who conducted the article,s research and G...
(Date:11/9/2009)...re/ -- Celling Technologies, a subsidiary of Spine...is, Inc. to research potential applications for ad... acquired the global rights in spine for Tissue Ge...nology in November of 2007. Replacing the prior a...lling Technologies to further research adipose tis...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 1HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 2HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 1Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 2Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 5Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 6Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 1Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 2Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 3Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 6
...sdaq: TELK ) reported positive preclinical data f...ecule inhibitors of validated cancer targets,inclu...ented today at the,AACR-NCI-EORTC Conference on Mo...ncisco. Aurora kinases are enzymes that play a ke...-expressed in many human cancers, including breast...
...., a,privately held biopharmaceutical company deve...cular biomarker data demonstrating the overexpress...in in multiple cancers,including ovarian, breast a...ation of PARP overexpression in specific types of ...inical development of the company,s,pipeline of PA...
Other Medicine Technology:Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2 2BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types 2
Neuro-Cool™ Cool Head Wrap
...noWELL Mycoplasma Pneumoniae Antibody (IgG) Test i...the detection of clinically significant IgG antibo...nt human serum specimens. The test should not be u...ycoplasma Pneumoniae Antibody (IgM) Test and is no...
ImmunoDOT Mono M Test
...noWELL VCA IgG Test is an ELISA method for the qua... Virus viral capsid antigen (VCA) in human serum. ...other testing such as the EBV nuclear antigen (EBN...heterophile tests, the results can serve as an aid...
Medicine Products: